Ming Sun
0009-0004-7160-7667
1 paper found
Refreshing results…
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies
Missing publications? Search for publications with a matching author name.